Timothy M Mayleben

Timothy M Mayleben has an estimated net worth of $11.1 Million. This is based on reported shares across multiple companies, which include NightHawk Radiology Holdings Inc, MARINUS PHARMACEUTICALS, INC., AASTROM BIOSCIENCES INC, Esperion Therapeutics, Inc., Loxo Oncology, Inc., Landos Biopharma, Inc., AKSYS LTD, and ESPERION THERAPEUTICS INC/MI.

2019 was Timothy M Mayleben's most active year for acquiring shares with 10 total transactions. Timothy M Mayleben's most active month to acquire stocks was the month of December. 2019 was Timothy M Mayleben's most active year for disposing of shares, totalling 6 transactions. Timothy M Mayleben's most active month to dispose stocks was the month of January. 2011 saw Timothy M Mayleben paying a total of $1,695,381.60 for 751,257 shares, this is the most they've acquired in one year. In 2004 Timothy M Mayleben cashed out on 616,646 shares for a total of $4,423,020.00, their largest year based on trade value.